Skip to main content
Erschienen in: European Radiology 10/2019

14.03.2019 | Head and Neck

Radiomics on multi-modalities MR sequences can subtype patients with non-metastatic nasopharyngeal carcinoma (NPC) into distinct survival subgroups

verfasst von: En-Hong Zhuo, Wei-Jing Zhang, Hao-Jiang Li, Guo-Yi Zhang, Bing-Zhong Jing, Jian Zhou, Chun-Yan Cui, Ming-Yuan Chen, Ying Sun, Li-Zhi Liu, Hong-Min Cai

Erschienen in: European Radiology | Ausgabe 10/2019

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To explore and evaluate the feasibility of radiomics in stratifying nasopharyngeal carcinoma (NPC) into distinct survival subgroups through multi-modalities MRI.

Methods

A total of 658 patients (training cohort: 424; validation cohort: 234) with non-metastatic NPC were enrolled in the retrospective analysis. Each slice was considered as a sample and 4863 radiomics features on the tumor region were extracted from T1-weighted, T2-weighted, and contrast-enhanced T1-weighted MRI. Consensus clustering and manual aggregation were performed on the training cohort to generate a baseline model and classification reference used to train a support vector machine classifier. The risk of each patient was defined as the maximum risk among the slices. Each patient in the validation cohort was assigned to the risk model using the trained classifier. Harrell’s concordance index (C-index) was used to measure the prognosis performance, and differences between subgroups were compared using the log-rank test.

Results

The training cohort was clustered into four groups with distinct survival patterns. Each patient was assigned to one of the four groups according to the estimated risk. Our method gave a performance (C-index = 0.827, p < .004 and C-index = 0.814, p < .002) better than the T-stage (C-index = 0.815, p = .002 and C-index = 0.803, p = .024), competitive to and more stable than the TNM staging system (C-index = 0.842, p = .003 and C-index = 0.765, p = .050) in the training cohort and the validation cohort.

Conclusions

Through investigating a large one-institutional cohort, the quantitative multi-modalities MRI image phenotypes reveal distinct survival subtypes.

Key Points

• Radiomics phenotype of MRI revealed the subtype of nasopharyngeal carcinoma (NPC) patients with distinct survival patterns.
• The slice-wise analysis method on MRI helps to stratify patients and provides superior prognostic performance over the TNM staging method.
• Risk estimation using the highest risk among slices performed better than using the majority risk in prognosis.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Yao J, Zhou G, Wang Y et al (2017) Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein–Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma. Chin J Cancer 36:98CrossRefPubMedPubMedCentral Yao J, Zhou G, Wang Y et al (2017) Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein–Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma. Chin J Cancer 36:98CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Feng X, Lin J, Xing S, Liu W, Zhang G (2017) Higher IGFBP-1 to IGF-1 serum ratio predicts unfavourable survival in patients with nasopharyngeal carcinoma. BMC Cancer 17:90CrossRefPubMedPubMedCentral Feng X, Lin J, Xing S, Liu W, Zhang G (2017) Higher IGFBP-1 to IGF-1 serum ratio predicts unfavourable survival in patients with nasopharyngeal carcinoma. BMC Cancer 17:90CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Zhang L, Li Y, Hu J et al (2018) Proposal of a pretreatment nomogram for predicting local recurrence after intensity-modulated radiation therapy in t4 nasopharyngeal carcinoma: a retrospective review of 415 Chinese patients. Cancer Res Treat 50:1084CrossRefPubMed Zhang L, Li Y, Hu J et al (2018) Proposal of a pretreatment nomogram for predicting local recurrence after intensity-modulated radiation therapy in t4 nasopharyngeal carcinoma: a retrospective review of 415 Chinese patients. Cancer Res Treat 50:1084CrossRefPubMed
4.
Zurück zum Zitat Xu Y, Zheng Z, Gao Y et al (2017) High expression of IMPDH2 is associated with aggressive features and poor prognosis of primary nasopharyngeal carcinoma. Sci Rep-UK 7:745CrossRef Xu Y, Zheng Z, Gao Y et al (2017) High expression of IMPDH2 is associated with aggressive features and poor prognosis of primary nasopharyngeal carcinoma. Sci Rep-UK 7:745CrossRef
5.
Zurück zum Zitat He S, Wang Y, Chen H et al (2016) C-reactive protein/albumin ratio (CAR) as a prognostic factor in patients with non-metastatic nasopharyngeal carcinoma. J Cancer 7:2360CrossRefPubMedPubMedCentral He S, Wang Y, Chen H et al (2016) C-reactive protein/albumin ratio (CAR) as a prognostic factor in patients with non-metastatic nasopharyngeal carcinoma. J Cancer 7:2360CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Yuan H, Ai Q, Kwong DL et al (2017) Cervical nodal volume for prognostication and risk stratification of patients with nasopharyngeal carcinoma, and implications on the TNM-staging system. Sci Rep-UK 7:10387CrossRef Yuan H, Ai Q, Kwong DL et al (2017) Cervical nodal volume for prognostication and risk stratification of patients with nasopharyngeal carcinoma, and implications on the TNM-staging system. Sci Rep-UK 7:10387CrossRef
7.
Zurück zum Zitat Du X, Tang L, Mao Y et al (2016) Circulating EBV DNA, globulin and nodal size predict distant metastasis after intensity-modulated radiotherapy in stage II nasopharyngeal carcinoma. J Cancer 7:664CrossRefPubMedPubMedCentral Du X, Tang L, Mao Y et al (2016) Circulating EBV DNA, globulin and nodal size predict distant metastasis after intensity-modulated radiotherapy in stage II nasopharyngeal carcinoma. J Cancer 7:664CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Chang S, Chan T, Chen T, Lee S, Lin L, Win KT (2017) HOXC6 overexpression is associated with ki-67 expression and poor survival in NPC patients. J Cancer 8:1647CrossRefPubMedPubMedCentral Chang S, Chan T, Chen T, Lee S, Lin L, Win KT (2017) HOXC6 overexpression is associated with ki-67 expression and poor survival in NPC patients. J Cancer 8:1647CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat He Y, Jing Y, Wei F et al (2018) Long non-coding RNA PVT1 predicts poor prognosis and induces radioresistance by regulating DNA repair and cell apoptosis in nasopharyngeal carcinoma. Cell Death Dis 9:235CrossRefPubMedPubMedCentral He Y, Jing Y, Wei F et al (2018) Long non-coding RNA PVT1 predicts poor prognosis and induces radioresistance by regulating DNA repair and cell apoptosis in nasopharyngeal carcinoma. Cell Death Dis 9:235CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Aerts HJWL, Velazquez ER, Leijenaar RTH et al (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5 Aerts HJWL, Velazquez ER, Leijenaar RTH et al (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5
12.
Zurück zum Zitat Huang Y, Liang C, He L et al (2016) Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J Clin Oncol 34:2157–2164CrossRefPubMed Huang Y, Liang C, He L et al (2016) Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J Clin Oncol 34:2157–2164CrossRefPubMed
13.
Zurück zum Zitat Kickingereder P, Burth S, Wick A et al (2016) Radiomic profiling of glioblastoma: identifying an imaging predictor of patient survival with improved performance over established clinical and radiologic risk models. Radiology 280:880–889CrossRefPubMed Kickingereder P, Burth S, Wick A et al (2016) Radiomic profiling of glioblastoma: identifying an imaging predictor of patient survival with improved performance over established clinical and radiologic risk models. Radiology 280:880–889CrossRefPubMed
14.
Zurück zum Zitat Li H, Zhu Y, Burnside ES et al (2016) MR imaging radiomics signatures for predicting the risk of breast cancer recurrence as given by research versions of MammaPrint, Oncotype DX, and PAM50 gene assays. Radiology 281:382–391CrossRefPubMedPubMedCentral Li H, Zhu Y, Burnside ES et al (2016) MR imaging radiomics signatures for predicting the risk of breast cancer recurrence as given by research versions of MammaPrint, Oncotype DX, and PAM50 gene assays. Radiology 281:382–391CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Lv W, Yuan Q, Wang Q et al (2018) Robustness versus disease differentiation when varying parameter settings in radiomics features: application to nasopharyngeal PET/CT. Eur Radiol:1–10 Lv W, Yuan Q, Wang Q et al (2018) Robustness versus disease differentiation when varying parameter settings in radiomics features: application to nasopharyngeal PET/CT. Eur Radiol:1–10
16.
Zurück zum Zitat Zhang B, Tian J, Dong D et al (2017) Radiomics features of multiparametric MRI as novel prognostic factors in advanced nasopharyngeal carcinoma. Clin Cancer Res 23:4259–4269CrossRefPubMed Zhang B, Tian J, Dong D et al (2017) Radiomics features of multiparametric MRI as novel prognostic factors in advanced nasopharyngeal carcinoma. Clin Cancer Res 23:4259–4269CrossRefPubMed
17.
Zurück zum Zitat Zhang B, He X, Ouyang F et al (2017) Radiomic machine-learning classifiers for prognostic biomarkers of advanced nasopharyngeal carcinoma. Cancer Lett 403:21–27CrossRefPubMed Zhang B, He X, Ouyang F et al (2017) Radiomic machine-learning classifiers for prognostic biomarkers of advanced nasopharyngeal carcinoma. Cancer Lett 403:21–27CrossRefPubMed
18.
Zurück zum Zitat Liu J, Mao Y, Li Z et al (2016) Use of texture analysis based on contrast-enhanced MRI to predict treatment response to chemoradiotherapy in nasopharyngeal carcinoma. J Magn Reson Imaging 44:445–455CrossRefPubMed Liu J, Mao Y, Li Z et al (2016) Use of texture analysis based on contrast-enhanced MRI to predict treatment response to chemoradiotherapy in nasopharyngeal carcinoma. J Magn Reson Imaging 44:445–455CrossRefPubMed
19.
Zurück zum Zitat Wang G, He L, Yuan C, Huang Y, Liu Z, Liang C (2018) Pretreatment MR imaging radiomics signatures for response prediction to induction chemotherapy in patients with nasopharyngeal carcinoma. Eur J Radiol 98:100–106CrossRefPubMed Wang G, He L, Yuan C, Huang Y, Liu Z, Liang C (2018) Pretreatment MR imaging radiomics signatures for response prediction to induction chemotherapy in patients with nasopharyngeal carcinoma. Eur J Radiol 98:100–106CrossRefPubMed
20.
Zurück zum Zitat Mao J, Fang J, Duan X et al (2019) Predictive value of pretreatment MRI texture analysis in patients with primary nasopharyngeal carcinoma. Eur Radiol:1–9 Mao J, Fang J, Duan X et al (2019) Predictive value of pretreatment MRI texture analysis in patients with primary nasopharyngeal carcinoma. Eur Radiol:1–9
21.
Zurück zum Zitat Liu H, Zhao R, Fang H, Cheng F, Fu Y, Liu Y (2017) Entropy-based consensus clustering for patient stratification. Bioinformatics 33:2691–2698CrossRefPubMed Liu H, Zhao R, Fang H, Cheng F, Fu Y, Liu Y (2017) Entropy-based consensus clustering for patient stratification. Bioinformatics 33:2691–2698CrossRefPubMed
22.
Zurück zum Zitat Amin MB, Edge S, Greene F et al (2017) AJCC cancer staging manual. Springer, New YorkCrossRef Amin MB, Edge S, Greene F et al (2017) AJCC cancer staging manual. Springer, New YorkCrossRef
23.
Zurück zum Zitat Pan J, Xu Y, Qiu S et al (2015) A comparison between the Chinese 2008 and the 7th edition AJCC staging systems for nasopharyngeal carcinoma. Am J Clin Oncol 38:189–196CrossRefPubMed Pan J, Xu Y, Qiu S et al (2015) A comparison between the Chinese 2008 and the 7th edition AJCC staging systems for nasopharyngeal carcinoma. Am J Clin Oncol 38:189–196CrossRefPubMed
24.
Zurück zum Zitat Tang L, Chen Y, Mao Y et al (2017) Validation of the 8th edition of the UICC/AJCC staging system for nasopharyngeal carcinoma from endemic areas in the intensity-modulated radiotherapy era. J Natl Compr Canc Netw 15:913–919CrossRefPubMed Tang L, Chen Y, Mao Y et al (2017) Validation of the 8th edition of the UICC/AJCC staging system for nasopharyngeal carcinoma from endemic areas in the intensity-modulated radiotherapy era. J Natl Compr Canc Netw 15:913–919CrossRefPubMed
25.
Zurück zum Zitat Kang M, Zhou P, Li G et al (2017) Validation of the 8th edition of the UICC/AJCC staging system for nasopharyngeal carcinoma treated with intensity-modulated radiotherapy. Oncotarget 8:70586PubMedPubMedCentral Kang M, Zhou P, Li G et al (2017) Validation of the 8th edition of the UICC/AJCC staging system for nasopharyngeal carcinoma treated with intensity-modulated radiotherapy. Oncotarget 8:70586PubMedPubMedCentral
26.
Zurück zum Zitat Lambin P, Rios-Velazquez E, Leijenaar R et al (2012) Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer 48:441–446CrossRefPubMedPubMedCentral Lambin P, Rios-Velazquez E, Leijenaar R et al (2012) Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer 48:441–446CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Ma Z, Fang M, Huang Y et al (2017) CT-based radiomics signature for differentiating Borrmann type IV gastric cancer from primary gastric lymphoma. Eur J Radiol 91:142–147CrossRefPubMed Ma Z, Fang M, Huang Y et al (2017) CT-based radiomics signature for differentiating Borrmann type IV gastric cancer from primary gastric lymphoma. Eur J Radiol 91:142–147CrossRefPubMed
28.
Zurück zum Zitat Huang Y, Liu Z, He L et al (2016) Radiomics signature: a potential biomarker for the prediction of disease-free survival in early-stage (i or ii) non-small cell lung cancer. Radiology 281:947–957CrossRefPubMed Huang Y, Liu Z, He L et al (2016) Radiomics signature: a potential biomarker for the prediction of disease-free survival in early-stage (i or ii) non-small cell lung cancer. Radiology 281:947–957CrossRefPubMed
Metadaten
Titel
Radiomics on multi-modalities MR sequences can subtype patients with non-metastatic nasopharyngeal carcinoma (NPC) into distinct survival subgroups
verfasst von
En-Hong Zhuo
Wei-Jing Zhang
Hao-Jiang Li
Guo-Yi Zhang
Bing-Zhong Jing
Jian Zhou
Chun-Yan Cui
Ming-Yuan Chen
Ying Sun
Li-Zhi Liu
Hong-Min Cai
Publikationsdatum
14.03.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 10/2019
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-019-06075-1

Weitere Artikel der Ausgabe 10/2019

European Radiology 10/2019 Zur Ausgabe

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.